List of Exelixis patents

Patents where

Current Assignee

Name

Exelixis

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 8211929 Pyrimidine derivatives as kinase modulators and method of use	Patent 8211929 was granted and assigned to Exelixis on July, 2012 by the United States Patent and Trademark Office.		Exelixis	United States Patent and Trademark Office	8211929	July 3, 2012
‌ US Patent 7704995 Protein kinase modulators and methods of use	Patent 7704995 was granted and assigned to Exelixis on April, 2010 by the United States Patent and Trademark Office.		Exelixis	United States Patent and Trademark Office	7704995	April 27, 2010
‌ US Patent 8067436 c-Met modulators and methods of use	Patent 8067436 was granted and assigned to Exelixis on November, 2011 by the United States Patent and Trademark Office.		Exelixis	United States Patent and Trademark Office	8067436	November 29, 2011
‌ US Patent 7579473 c-Met modulators and methods of use	Patent 7579473 was granted and assigned to Exelixis on August, 2009 by the United States Patent and Trademark Office.		Exelixis	United States Patent and Trademark Office	7579473	August 25, 2009
‌ US Patent 7498358 Human ADAM-10 inhibitors	Patent 7498358 was granted and assigned to Exelixis on March, 2009 by the United States Patent and Trademark Office.		Exelixis	United States Patent and Trademark Office	7498358	March 3, 2009
‌ US Patent 9809549 Malate salt of N-(4-{[6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N′(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms therof for the treatment of cancer	Patent 9809549 was granted and assigned to Exelixis on November, 2017 by the United States Patent and Trademark Office.	Exelixis	Exelixis	United States Patent and Trademark Office	9809549	November 7, 2017
‌ US Patent 7803839 Azetidines as MEK inhibitors for the treatment of proliferative diseases	Patent 7803839 was granted and assigned to Exelixis on September, 2010 by the United States Patent and Trademark Office.		Exelixis	United States Patent and Trademark Office	7803839	September 28, 2010
‌ US Patent 8476298 c-Met modulators and method of use	Patent 8476298 was granted and assigned to Exelixis on July, 2013 by the United States Patent and Trademark Office.		Exelixis	United States Patent and Trademark Office	8476298	July 2, 2013
‌ US Patent 8178532 c-Met modulators and method of use	Patent 8178532 was granted and assigned to Exelixis on May, 2012 by the United States Patent and Trademark Office.		Exelixis	United States Patent and Trademark Office	8178532	May 15, 2012
‌ US Patent 7998995 LXR and FXR modulators	Patent 7998995 was granted and assigned to Exelixis on August, 2011 by the United States Patent and Trademark Office.		Exelixis	United States Patent and Trademark Office	7998995	August 16, 2011
‌ US Patent 11504363 Method of treating cancer and bone cancer pain	Patent 11504363 was granted and assigned to Exelixis on November, 2022 by the United States Patent and Trademark Office.	Exelixis	Exelixis	United States Patent and Trademark Office	11504363	November 22, 2022
‌ US Patent 7989622 Phosphatidylinositol 3-kinase inhibitors and methods of their use	Patent 7989622 was granted and assigned to Exelixis on August, 2011 by the United States Patent and Trademark Office.		Exelixis	United States Patent and Trademark Office	7989622	August 2, 2011
‌ US Patent 8673912 Crystalline Forms on N-[3-fluoro-4-({6-(methyloxy)-7-[(3-morpholin-4-ylpropyl)oxy]-quinolin-4-yl}oxy)phenyl]-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide	Patent 8673912 was granted and assigned to Exelixis on March, 2014 by the United States Patent and Trademark Office.		Exelixis	United States Patent and Trademark Office	8673912	March 18, 2014
‌ US Patent 7413910 Multi-well apparatus	Patent 7413910 was granted and assigned to Exelixis on August, 2008 by the United States Patent and Trademark Office.		Exelixis	United States Patent and Trademark Office	7413910	August 19, 2008
‌ US Patent 8440663 4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as JAK-2 modulators and methods of use	Patent 8440663 was granted and assigned to Exelixis on May, 2013 by the United States Patent and Trademark Office.		Exelixis	United States Patent and Trademark Office	8440663	May 14, 2013
‌ US Patent 8013156 Tie-2 modulators and methods of use	Patent 8013156 was granted and assigned to Exelixis on September, 2011 by the United States Patent and Trademark Office.		Exelixis	United States Patent and Trademark Office	8013156	September 6, 2011
‌ US Patent 8012956 Tropane compounds	Patent 8012956 was granted and assigned to Exelixis on September, 2011 by the United States Patent and Trademark Office.		Exelixis	United States Patent and Trademark Office	8012956	September 6, 2011
‌ US Patent 11504362 Liquid dosage forms to treat cancer	Patent 11504362 was granted and assigned to Exelixis on November, 2022 by the United States Patent and Trademark Office.	Exelixis	Exelixis	United States Patent and Trademark Office	11504362	November 22, 2022
‌ US Patent 7977345 c-MET modulators and method of use	Patent 7977345 was granted and assigned to Exelixis on July, 2011 by the United States Patent and Trademark Office.		Exelixis	United States Patent and Trademark Office	7977345	July 12, 2011
‌ US Patent 8222256 Methods of using IGFIR and ABL kinase modulators	Patent 8222256 was granted and assigned to Exelixis on July, 2012 by the United States Patent and Trademark Office.		Exelixis	United States Patent and Trademark Office	8222256	July 17, 2012
‌ US Patent 11597699 MEK inhibitors and methods of their use		Exelixis	Exelixis	United States Patent and Trademark Office	11597699	March 7, 2023
‌ US Patent 7485634 Azepinoindole and pyridoindole derivatives as pharmaceutical agents	Patent 7485634 was granted and assigned to Exelixis on February, 2009 by the United States Patent and Trademark Office.		Exelixis	United States Patent and Trademark Office	7485634	February 3, 2009
‌ US Patent 9717720 Processes for preparing quinoline compounds and pharmaceutical compositions containing such compounds	Patent 9717720 was granted and assigned to Exelixis on August, 2017 by the United States Patent and Trademark Office.		Exelixis	United States Patent and Trademark Office	9717720	August 1, 2017
‌ US Patent 7265131 Isoquinolinone derivatives and their use as therapeutic agents	Patent 7265131 was granted and assigned to Exelixis on September, 2007 by the United States Patent and Trademark Office.		Exelixis	United States Patent and Trademark Office	7265131	September 4, 2007
‌ US Patent 8101625 Pyrimidinones as Casein Kinase II (CK2) modulators	Patent 8101625 was granted and assigned to Exelixis on January, 2012 by the United States Patent and Trademark Office.		Exelixis	United States Patent and Trademark Office	8101625	January 24, 2012

...

Results per page:

119 results

0 selected

119 results

0 selected